DJO Global said this week that it hired Jeffery McCaully as global president of its surgical business, effectively immediately. McCaulley succeeded Brady Shirley, who was named DJO’s president & CEO in November last year. McCaulley previously served as president & CEO of Smiths Medical, as well as president of Zimmer Biomet‘s (NYSE:ZBH) global reconstructive unit, where […]
HeartFlow
HeartFlow, Siemens Healthineers ink CAD diagnostic dev deal
Siemens (NYSE:SI) Healthineers and HeartFlow said yesterday they inked a global collaborative deal to develop a solution for diagnosing and managing patients with suspected coronary artery disease. The collaborative deal will join CT Scanners from Siemens Healthineers with HeartFlow’s FFRct Analysis fractional flow reserve software to create personalized 3D models of each patients’ arteries while computer […]
HeartFlow wins nod from U.K. healthcare board
The U.K.’s National Institute for Health & Care Excellence issued final guidance on HeartFlow‘s FFRct technology, which uses algorithms to generate 3D models of blood flows and can help diagnose heart disease. The British agency recommended the use of FFRct for patients with stable, recent-onset chest pain, finding that the technology is safe, has a high level of diagnostic […]
HeartFlow wins Japanese approval for FFRct tech
HeartFlow said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its HeartFlow FFRct technology, which uses algorithms to generate 3D models of blood flows and can help diagnose heart disease. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result […]
UK’s NICE set to recommend Heartflow’s FFRct
The U.K.’s National Institute for Health and Care Excellence last Friday released guidance supporting HeartFlow‘s FFRct technology, which uses algorithms to generate 3D models of blood flows and can help diagnose heart disease. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded […]
HeartFlow launches new FFRct cardiac imaging platform
HeartFlow said today that it’s launching a new version of its cardiac imaging platform, which uses algorithms to generate a 3D model of blood as it flows through the heart. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the […]
Boston Scientific’s Synergy stent at 2 years | ACC 2016 roundup
Evolve II: 2-year data for Boston Scientific’s Synergy stent Boston Scientific‘s (NYSE:BSX) Synergy stent showed non-inferiority to its Promus Element Plus device after 12 months, according to data from the Evolve II trial presented yesterday at the annual conference of the American College of Cardiology. The Synergy stent’s bioresorbable polymer coating is designed to dissolve completely […]
FDA finalizes Class II status for HeartFlow’s FFRct software
HeartFlow‘s non-invasive CT-guided fractional flow reserve software has been reclassified as a class II medical device by the FDA, according to a posting from the agency published today. The FDA classifies medical devices dependent upon based on their “risks and the regulatory controls necessary to provide a reasonable assurance of safety and effectiveness.” HeartFlow’s FFRCT test uses […]
TCT 2015: HeartFlow’s CT-based FFR lowers costs, improves quality of life
A non-invasive test of cardiac function made by HeartFlow lowered the cost of care and delivered improved quality of life scores compared to standard care, according to a study presented yesterday at the annual Transcatheter Cardiovascular Therapeutics conference. HeartFlow’s FFRCT test uses data from a standard CT scan to create a 3D map of the changes in blood flow […]
ESC Congress 2015: St. Jude, HeartFlow tout FFR-guided PCI
The European Society of Cardiology Congress conference wrapped up this week in London. Here’s a roundup of news from the overseas meeting of interventional cardiologists, dominated by data on fractional flow reserve technology. FFR: St. Jude touts 5 year data showing long-term benefits St. Jude Medical (NYSE:STJ) released 5-year data from a trial comparing the use […]
HeartFlow study shows reduced unnecessary ICA with FFRct
HeartFlow presented data from a clinical trial of its FFRct analysis that showed a significant reduction in unnecessary invasive coronary angiography after evaluation with the device. The data was presented at European Society of Cardiology’s annual meeting in London today. HeartFlow’s FFRct platform is an imaging approach that helps physicians treat coronary artery disease by getting […]